{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:08:59Z","timestamp":1744157339017,"version":"3.37.3"},"reference-count":31,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Xenobiotica"],"published-print":{"date-parts":[[2020,10,2]]},"DOI":"10.1080\/00498254.2020.1756007","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T08:06:09Z","timestamp":1586851569000},"page":"1149-1157","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Assessment of <i>in\u00a0vitro<\/i> inhibitory effects of novel anti MRSA benzoquinolizine fluoroquinolone WCK 771 (levonadifloxacin) and its metabolite on human liver cytochrome P450 enzymes"],"prefix":"10.1080","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5611-5251","authenticated-orcid":false,"given":"Rajesh","family":"Chavan","sequence":"first","affiliation":[{"name":"Wockhardt Research Centre, Aurangabad, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vineet","family":"Zope","sequence":"additional","affiliation":[{"name":"Wockhardt Research Centre, Aurangabad, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilesh","family":"Chavan","sequence":"additional","affiliation":[{"name":"Wockhardt Research Centre, Aurangabad, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javeed","family":"Shaikh","sequence":"additional","affiliation":[{"name":"Wockhardt Research Centre, Aurangabad, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0597-1303","authenticated-orcid":false,"given":"Kiran","family":"Patil","sequence":"additional","affiliation":[{"name":"Wockhardt Research Centre, Aurangabad, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4812-4259","authenticated-orcid":false,"given":"Ravindra","family":"Yeole","sequence":"additional","affiliation":[{"name":"Wockhardt Research Centre, Aurangabad, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5943-5031","authenticated-orcid":false,"given":"Sachin","family":"Bhagwat","sequence":"additional","affiliation":[{"name":"Wockhardt Research Centre, Aurangabad, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5128-4061","authenticated-orcid":false,"given":"Mahesh","family":"Patel","sequence":"additional","affiliation":[{"name":"Wockhardt Research Centre, Aurangabad, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,4,22]]},"reference":[{"key":"CIT0001","unstructured":"Bayer HealthCare Pharmaceuticals Inc. (2010). Highlights of prescribing Information: AVELOX (moxifloxacin hydrochloride) Film coated tablet, injection, solution for IV use. Available from: www.accessdata.fda.gov\/drugsatfda_docs\/label"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00641-06"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S229882"},{"key":"CIT0005","unstructured":"Chugh R, Lakdavala F, Bhatia A. (2016). Safety and pharmacokinetics of multiple ascending doses of WCK 771 and WCK 2349. In: Abstracts of the 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); Amsterdam, Netherlands. Abstract P1268. Basel, Switzerland: European Society of Clinical Microbiology and Infectious Diseases."},{"key":"CIT0006","unstructured":"Chugh R, Lakdavla F, Bhagwat S, et\u00a0al. (2015). Food effect and absolute bioavailability study of WCK 2349 and WCK 771 in healthy adult human volunteers in U.S. In: Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); San Diego, CA. Abstract A-039. Washington, DC: American Society for Microbiology."},{"key":"CIT0007","first-page":"23","volume":"29","author":"Dierks EA","year":"2001","journal-title":"Drug Metab. Dispos"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.16.253S.33993"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-3589(08)60200-8"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-014-0219-4"},{"key":"CIT0011","unstructured":"Ivaturi V, Niu J, Chugh R, et\u00a0al. (2015). Population pharmacokinetics of levonadifloxacin administered as WCK 2349, a novel oral benzoquinolizine quinolone prodrug. In: Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); San Diego, CA. Abstract A-033. Washington, DC: American Society for Microbiology."},{"key":"CIT0012","unstructured":"Janssen Ortho LLC. 2008: Highlights of prescribing Information: LEVAQUIN (Levofloxacin) Tablets, oral solution, injection for intravenous use. Available from: www.accessdata.fda.gov\/drugsatfda_docs\/label"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00073.x"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.2110"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2006.07.004"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1002\/jat.1720"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.2174\/157488409789375348"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-014-0201-1"},{"key":"CIT0019","unstructured":"Mason JW, Chugh R, Lakdavala F, Bhatia A. (2016). Electrocardiographic effects of WCK 2349. In: Abstracts of the 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); Amsterdam, Netherlands. Abstract P1269. Basel, Switzerland: European Society of Clinical Microbiology and Infectious Diseases."},{"key":"CIT0020","unstructured":"Melinta Therapeutics. (2017). Highlights of prescribing Information: BAXDELA (Delafloxacin) Tablet for oral use, oral suspension, injection for intravenous use. Available from: www.accessdata.fda.gov\/drugsatfda_docs\/label"},{"key":"CIT0021","unstructured":"Niu J, Ivaturi V, Niu J, et\u00a0al. (2015). Pharmacokinetics of levonadifloxacin administered as intravenous WCK 771 and oral WCK 2349 in healthy Indian male adults. In: Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, CA. Abstract A-032. Washington, DC: American Society for Microbiology."},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1086\/321846"},{"key":"CIT0024","unstructured":"Preston RA, Chugh R, Mastim M, Bhatia A. (2016). Single-center evaluation of the pharmacokinetics and safety of the novel fluoroquinolone WCK 2349 in hepatic impairment. In: Abstracts of the 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); Amsterdam, Netherlands. Abstract P1270. Basel, Switzerland: European Society of Clinical Microbiology and Infectious Diseases."},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01089-18"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-018-0520-8"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.32.6.647"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4532"},{"key":"CIT930337","doi-asserted-by":"publisher","DOI":"10.18433\/J30593"},{"key":"CIT3609541","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-016-0323-8"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1515\/DMDI.2004.20.3.143"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544030-00005"}],"container-title":["Xenobiotica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00498254.2020.1756007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T05:23:24Z","timestamp":1603776204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00498254.2020.1756007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,22]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,2]]}},"alternative-id":["10.1080\/00498254.2020.1756007"],"URL":"https:\/\/doi.org\/10.1080\/00498254.2020.1756007","relation":{},"ISSN":["0049-8254","1366-5928"],"issn-type":[{"type":"print","value":"0049-8254"},{"type":"electronic","value":"1366-5928"}],"subject":[],"published":{"date-parts":[[2020,4,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ixen20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ixen20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-01-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}